Johnson & Johnson recalls 5 spray sunscreens after carcinogen found

United States News News

Johnson & Johnson recalls 5 spray sunscreens after carcinogen found
United States Latest News,United States Headlines
  • 📰 TODAYshow
  • ⏱ Reading Time:
  • 17 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 10%
  • Publisher: 55%

The recall includes all can sizes and all levels of sun protection factor, or SPF.

The health care giant said the benzene was found after testing by the company and an independent laboratory. It is investigating how the chemical got into the products.

J&J said in a statement that “use of these products would not be expected to cause adverse health consequences" and that it voluntarily decided to recall them"out of an abundance of caution.” The statement added that people should use an alternate sunscreen to protect themselves from the skin cancer melanoma.

We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

TODAYshow /  🏆 389. in US

United States Latest News, United States Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

What are the symptoms of Guillain-Barré syndrome? Should I still get the J&J vaccine?What are the symptoms of Guillain-Barré syndrome? Should I still get the J&J vaccine?What to know about Guillain-Barré syndrome and Johnson & Johnson’s COVID-19 vaccine
Read more »

Johnson & Johnson in discussion with FDA regarding COVID-19 vaccine side effectsJohnson & Johnson in discussion with FDA regarding COVID-19 vaccine side effectsJohnson & Johnson (JNJ.N) said on Monday it was in discussions with the U.S. Food and Drug Administration about rare cases of a neurological disorder, Guillain-Barré syndrome, that have been reported following vaccination with the Janssen COVID-19 vaccine.
Read more »

Guillain-Barre syndrome explained, FDA warns of increased risk of GBS after Johnson & Johnson COVID vaccineGuillain-Barre syndrome explained, FDA warns of increased risk of GBS after Johnson & Johnson COVID vaccineThe severity of GBS, which causes muscle weakness, can range from mild to 'life-threatening' says the U.S. National Institutes of Health.
Read more »

The Johnson & Johnson COVID-19 Vaccine May Be Linked to a Rare Neurological ConditionThe Johnson & Johnson COVID-19 Vaccine May Be Linked to a Rare Neurological ConditionThe FDA added a new warning.
Read more »

FDA issues new warning on rare autoimmune disorder linked to J&J vaccineFDA issues new warning on rare autoimmune disorder linked to J&J vaccineFDA warns of increased risk of Guillain-Barre, a rare neurological disorder, following the Johnson & Johnson vaccine after 100 preliminary cases of the syndrome were reported among the 12.5 million doses administered.
Read more »



Render Time: 2025-02-27 06:07:11